Public note
For situational awareness and research transparency. Not medical advice.
System-generated assessment. This assessment remains under review until the stated horizon or until sufficient evidence allows evaluation.
High confidence
Evidence is strong and consistent, while still subject to revision as new data arrives. Based on 22 linked evidence items and assessed against Apr 30, 2026.
Confidence trend
Up 7 pts from the previous update
02
The criteria the system uses to determine whether this assessment is borne out by the stated horizon.
Method
The condition the system checks for when evaluating this assessment.
Minimum source quality
Evidence must meet or exceed this credibility tier to count toward evaluation.
Required terms
mpoxclade IbconfirmedOutcome
WHO DON confirmed mpox clade Ib cases in Rwanda and Uganda, satisfying the geographic expansion criterion of 2+ East African countries outside DRC.
03
Tracking since Jan 10, 2026.
07
0 linked items.
No linked evidence is available for this assessment yet.